Keywords: minimally invasive; mitral valve; outcomes; costs; health care economicsICU, intensive care unit; IQR, interquartile range4.3; 28; 35.4; 35.4.1
مقالات ISI ترجمه شده
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: heart; valve; mitral valve; valve repair; complication; gradient; 35.4.1;
Keywords: 28; 35; 35.4; 35.4.1;
Keywords: 35.4; 35.4.1; 35.4.2; BASF; Beneficiary Annual Summary Files; CI; confidence interval; CMS; Centers for Medicare and Medicaid Services; HR; hazard ratio; MEDPAR; Medicare Provider Analysis and Review; NIS; Nationwide Inpatient Sample; OR; odds ratio; STS;
Keywords: 35; 35.4; 35.4.1; AUC; area under the curve; CABG; coronary artery bypass grafting; CTSN; Cardiothoracic Surgical Trials Network; EDV; end-diastolic volume; EROA; effective regurgitant orifice area; IMR; ischemic mitral regurgitation; LV; left ventricle;
Keywords: mitral valve surgery; severe ischemic mitral valve regurgitation; clinical trial; MR; mitral regurgitation; MV; mitral valve; LV; left ventricle; CTSN; Cardiothoracic Surgical Trials Network; 35.4; 35.4.1; 35.4.2;
Keywords: 28; 31.4; 35.4.1; LIMV; less-invasive mitral valve surgery; TEE; transesophageal echocardiography; TERMR; totally endoscopic robotic mitral valve repair;
Keywords: 26.1.4; 35.2; 35.4; 35.4.1; AVR; aortic valve replacement; CABG; coronary artery bypass grafting; MR; mitral regurgitation; TTE; transthoracic echocardiogram;
Keywords: 35.4.1; 38.2; CABG; coronary artery bypass grafting; CI; confidence interval; HR; hazard ratio; IMR; ischemic mitral regurgitation; LV; left ventricular; LVEF; left ventricular ejection fraction; MR; mitral regurgitation; NR-MA; nonrestrictive mitral annu
Keywords: 35; 35.4; 35.4.1; ALP; anterior mitral leaflet prolapse; EE; edge-to-edge; MR; mitral valve regurgitation; MV; mitral valve;
Keywords: 31.4; 35.4; 35.4.1; EuroSCORE; European System for Cardiac Operative Risk Evaluation; ICU; intensive care unit; MV; mitral valve;
Keywords: 35.4; 35.4.1; LA; left atrial; LV; left ventricular; NF; no fold; PF; partial foldoplasty; SAM; systolic anterior motion;
Keywords: 28; 35.4; 35.4.1; ACC; aortic crossclamping; AF; atrial fibrillation; CPB; cardiopulmonary bypass; IQR; interquartile range; MICS; minimally invasive cardiac surgery; MR; mitral regurgitation; MV; mitral valve; TAP; tricuspid annuloplasty; TEE; transesoph
Keywords: 23.1.4; 35.4; 35.4.1; 38.2BNP, brain natriuretic peptide; CABG, coronary artery bypass grafting; ERO, effective regurgitation orifice; FIMR, functional ischemic mitral regurgitation; QOL, quality of life; LA, left atrial; LV, left ventricular; LVEF, LV ej
Keywords: 35; 35.4; 35.4.1; ACCESS-EU; ACCESS-EUROPE; DMR; degenerative mitral regurgitation; euroSCORE; European System for Cardiac Operative Risk Evaluation; EVEREST; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan; IQR; interquar
Keywords: 17; 35.4.1; CABG; coronary artery bypass graft; HOCM; hypertrophic obstructive cardiomyopathy; LVEF; left ventricular ejection fraction; LVOT; left ventricular outflow tract; SAM; systolic anterior motion; TEE; transesophageal echocardiogram;
Keywords: ACSD; Adult Cardiac Surgery Database; CHF; congestive heart failure; CI; confidence interval; ESRD; end-stage renal disease; OR; odds ratio; STS; Society of Thoracic Surgeons; 35.4; 35.4.1;
Keywords: 35; 35.4.1; 35.4.2; 36.2; AUC; area under the curve; EOA; effective orifice area; FIMR; functional ischemic mitral regurgitation; IEOA; indexed effective orifice area; LV; left ventricular; LVEF; left ventricular ejection fraction; LVOT; left ventricular
Keywords: 35; 35.4; 35.4.1; 36.4; cMRI; cardiac magnetic resonance imaging; CoA; coaptation area; CoL; coaptation length; DN; double neochordal implantation; ePTFE; expanded polytetrafluoroethylene; FePTFE; artificial suture tension; Fnc; native chordal tension; FP
Keywords: 35.4; 35.4.1; 35.4.2; ACSD; Adult Cardiac Surgery Database; MR; mitral regurgitation; MV; mitral valve; MVR; mitral valve replacement; PROM; Predicted Risk of Mortality; RCS; restricted cubic spline; STS; Society of Thoracic Surgeons; VCSQI; Virginia Card
Keywords: FMR; functional mitral regurgitation; LV EDD index; Left ventricular end-diastolic dimension index; MR; mitral regurgitation; SAM; systolic anterior motion; 17.1; 35.4; 35.4.1; 38.2;
Comparative long-term results of mitral valve repair in adults with chronic rheumatic disease and degenerative disease: Is repair for “burnt-out” rheumatic disease still inferior to repair for degenerative disease in the current era?
Keywords: 35; 35.4; 35.4.1; AF; atrial fibrillation; CI; confidence interval; HR; hazard ratio; MR; mitral regurgitation; MS; mitral stenosis; MV; mitral valve; NYHA; New York Heart Association; TEE; transesophageal echocardiography;
Biomechanical drawbacks of different techniques of mitral neochordal implantation: When an apparently optimal repair can fail
Keywords: mitral valve prolapse; mitral valve repair; mitral neochordoplasty; suture length; finite element models; cMRI; cardiac magnetic resonance imaging; CoA; coaptation area; DN; double neochorda; ePTFE; expanded polytetrafluoroethylene; FE; finite element; Fe
Mitral valve annuloplasty and anterior leaflet augmentation for functional ischemic mitral regurgitation: Quantitative comparison of coaptation and subvalvular tethering
Keywords: 35.4; 35.4.1; 38.2; ALA; anterior leaflet augmentation; FIMR; functional ischemic mitral regurgitation; LV; left ventricular; MR; mitral regurgitation; MV; mitral valve; PM; papillary muscle; RMA; restrictive mitral annuloplasty;
Preoperative heart failure in the Medicare population undergoing mitral valve repair and replacement: An opportunity for improvement
Keywords: 22; 35.4; 35.4.1; 35.4.2AHA, American Heart Association; BASF, Beneficiary Annual Summary Files; CABG, coronary artery bypass grafting; CI, confidence interval; CMS, Centers for Medicare and Medicaid Services; COPD, chronic obstructive pulmonary disease;
Minithoracotomy for mitral valve repair improves inpatient and postdischarge economic savings
Keywords: 28; 35.4; 35.4.1; ICD-9; International Classification of Diseases, Ninth Edition; IsoMVRep; isolated mitral valve repair;
Clinical experience with CorMatrix extracellular matrix in the surgical treatment of mitral valve disease
Keywords: 35; 35.4; 35.4.1; 39ECM, extracellular matrix; MV, mitral valve; MVr, mitral valve repair; MVR, mitral valve replacement
Left ventricular dysfunction after mitral valve repair-the fallacy of “normal” preoperative myocardial function
Keywords: 35.4; 35.4.1; CI; confidence interval; EF; ejection fraction; HR; hazard ratio; LV; left ventricular; LVESD; LV end-systolic diameter; MR; mitral valve regurgitation; OR; odds ratio; RVSP; right ventricular systolic pressure;
Operative outcomes in mitral valve surgery: Combined effect of surgeon and hospital volume in a population-based analysis
Keywords: ICD-9; International Classification of Diseases, Ninth Revision; NIS; Nationwide Inpatient Sample; STS; Society of Thoracic Surgeons; 35; 35.4; 35.4.1; 35.4.2;
Edge-to-edge repair for prevention and treatment of mitral valve systolic anterior motion
Keywords: A2, middle scallop of the anterior mitral leaflet; CPB, cardiopulmonary bypass; E2E, edge-to-edge; LVOT, left ventricular outflow tract; MV, mitral valve; SAM, systolic anterior motion; TEE, transesophageal echocardiography35.4; 35.4.1
Dynamic annuloplasty for mitral regurgitation
Keywords: 35; 35.4; 35.4.1; CPB; cardiopulmonary bypass; DYANA; Dynamic Annuloplasty System with Activation for the Treatment of Mitral Regurgitation; MACE; major adverse clinical event; MR; mitral regurgitation; MV; mitral valve; NYHA; New York Heart Association;
Influence of left ventricular function on development of systolic anterior motion after mitral valve repair
Keywords: CI; confidence interval; EF; ejection fraction; LV; left ventricular (ventricle); LVDs; systolic left ventricular dimension; MR; mitral regurgitation; RR; risk ratio; SAM; systolic anterior motion; 35.4.1;
Early mitral valve surgery for chronic severe mitral regurgitation optimizes left ventricular performance and left ventricular mass regression
Keywords: 35; 35.4; 35.4.1; 35.4.2Ea, effective arterial elastance; Ees, end-systolic elastance; Ea/Ees, ventriculoarterial coupling; EF, ejection fraction; LV, left ventricular; LVEDVI, LV end-diastolic volume index; LVESVI, LV end-systolic volume index; LVM, LV m
Minimally invasive approach provides at least equivalent results for surgical correction of mitral regurgitation: A propensity-matched comparison
Keywords: MR, mitral regurgitation28; 35; 35.4.1
Two-ventricle repairs in the unbalanced atrioventricular canal defect spectrum with midterm follow-up
Keywords: 20; 20.1; 35.4; 35.4.1; AV; atrioventricular; AVC; AV canal; AVV; AV valve; AVVI; AVV index; HAVV; hypoplastic AV valve; HV; hypoplastic ventricle; LV; left ventricle; MV; mitral valve; RV; right ventricle; SVR; single-ventricle repair; TV; tricuspid valv
Ideal site for ventricular anchoring of artificial chordae in mitral regurgitation
Keywords: 17; 35.4; 35.4.1; 36.4LV, left ventricular; PM, papillary muscle
Mitral valve reconstruction in Barlow disease: Long-term echographic results and implications for surgical management
Keywords: 35; 35.4; 35.4.1; 36.2LCOS, low cardiac output syndrome; MR, mitral regurgitation; MV, mitral valve; SAM, systolic anterior motion; TEE, transesophageal echocardiography
Comparative effectiveness of minimally invasive versus traditional sternotomy mitral valve surgery in elderly patients
Keywords: 28; 35.4; 35.4.1; 35.4.2CPB, cardiopulmonary bypass; MIMVS, minimally invasive mitral valve surgery
Mitral valve annuloplasty and papillary muscle relocation oriented by 3-dimensional transesophageal echocardiography for severe functional mitral regurgitation
Keywords: 35.4.1; 36.22D, 2-dimensional; 3D, 3-dimensional; FMR, functional mitral regurgitation; LV, left ventricle (ventricular); MR, mitral regurgitation; MVA, mitral valve apparatus; PPM, papillary muscle; PTFE, polytetrafluoroethylene; TOE, transesophageal ech
A heart team's perspective on interventional mitral valve repair: Percutaneous clip implantation as an important adjunct to a surgical mitral valve program for treatment of high-risk patients
Keywords: 22; 35.4; 35.4.1; CABG; coronary artery bypass grafting; euroSCORE; European System for Cardiac Operative Risk Evaluation; EVERESTÂ II; Endovascular Valve Edge-to-Edge Repair Study; MR; mitral regurgitation; MVR; mitral valve repair; NYHA; New York Heart
Fifteen-year experience with minimally invasive approach for reoperations involving the mitral valve
Keywords: 24; 28; 35.4.1; 35.4.2CABG, coronary artery bypass grafting; NYHA, New York Heart Association; STS, Society of Thoracic Surgeons
Right ventricular papillary muscle approximation as a novel technique of valve repair for functional tricuspid regurgitation in an ex vivo porcine model
Keywords: 20.1; 35; 35.4.1; 36.2; 3D; 3-dimensional; A-M; anterior papillary muscle to medial papillary muscle [suture position]; A-P; anterior papillary muscle to posterior papillary muscle [suture position]; A-S1; anterior papillary muscle to the midpoint between
Effect of anterior strut chordal transection on the force distribution on the marginal chordae of the mitral valve
Keywords: 35.4; 35.4.1; MR; mitral regurgitation;
One single dose of histidine–tryptophan–ketoglutarate solution gives equally good myocardial protection in elective mitral valve surgery as repetitive cold blood cardioplegia: A prospective randomized study
Keywords: 31.4; 35.4.1; 35.4.2CK, creatine kinase; HTK, histidine–tryptophan–ketoglutarate
Learning curve analysis of mitral valve repair using telemanipulative technology
Keywords: 28; 35.4; 35.4.1
Cardiac support device, restrictive mitral valve annuloplasty, and optimized medical treatment: A multimodality approach to nonischemic cardiomyopathy
Keywords: 22; 35.4.1; CRT; cardiac resynchronization therapy; CSD; cardiac support device; ICD; internal cardioverter defibrillator; IQR; interquartile range; LV; left ventricle (ventricular); MR; mitral regurgitation; NYHA; New York Heart Association;
Tricuspid annuloplasty prevents right ventricular dilatation and progression of tricuspid regurgitation in patients with tricuspid annular dilatation undergoing mitral valve repair
Keywords: 35; 35.4.1; 36; 36.2TR, tricuspid regurgitation
Changes in left ventricular twist after mitral valve repair
Keywords: 31.1; 35.4.1; 36.22D, 2-dimensional; CRT, cardiac resynchronization therapy; HR, heart rate; LV, left ventricle; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume; MR, mitra
Robotic mitral valve repair for all prolapse subsets using techniques identical to open valvuloplasty: Establishing the benchmark against which percutaneous interventions should be judged
Keywords: 28; 35.4; 35.4.1; CT; computed tomography; ICU; intensive care unit; MR; mitral regurgitation; MV; mitral valve; TTE; transthoracic echocardiography;